Adjuvant ipilimumab improves recurrence-free survival in high-risk stage III melanoma

HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer

Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

Comment: Adjuvant ipilimumab in high-risk melanoma

Comment: PD-1 targeting MK-3475 gives long-term responses in melanoma

Comment: Immunotherapy combo increases median survival in advanced melanoma

Success for ipilimumab and nivolumab combo in advanced melanoma

Comment: CALGB/SWOG 80405 study on chemo combos in colorectal

Discontinuing statins near the end of life is safe, improves patient quality of life

Impact of cytotoxics on pregnancy needs to be better understood

T-VEC injections into melanoma lesions show significant response rate

Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer